NCT00347711
Bevacizumab and Retinal Vascular Occlusions No drug interventions Not Available 3 withdrawn NCT01257815
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment treatment 4 completed NCT02661711
Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study treatment 2 completed NCT01566526
Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion Not Available Not Available completed NCT00403026
Intravitreal Bevacizumab for Retinal Disorders treatment Not Available unknown_status NCT01846299
To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema treatment 3 completed NCT04129021
High Resolution, High-speed Multimodal Ophthalmic Imaging No drug interventions other Not Available recruiting NCT06011798
Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE) treatment 2 active_not_recruiting NCT06595355
Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin No drug interventions treatment 2 / 3 recruiting NCT00942864
Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO) treatment 3 completed NCT01568021
Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO) No drug interventions Not Available Not Available completed NCT00804921
Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab Not Available 2 completed NCT01277302
A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion treatment 4 completed NCT00918554
Efficacy Study of Methotrexate to Treat Sarcoid-associated Uveitis treatment 4 terminated NCT02732951
Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema No drug interventions treatment 2 completed NCT02693353
Epiretinal Membrane and Pseudophakic Cystoid Macular Edema No drug interventions Not Available Not Available terminated NCT00308477
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion treatment 1 / 2 completed NCT01539577
A Long-Term Safety Study of OZURDEX® in Clinical Practice Not Available Not Available completed NCT04976777
A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the Retina treatment 3 completed NCT03660345
PPV With Internal Limiting Membrane Peeling for Treatment-Naïve DME No drug interventions treatment 3 completed NCT00801905
Effect of Topical Nepafenac in Macular Thickening Related to Pan-retinal Photocoagulation prevention 2 terminated NCT04740905
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion treatment 3 completed NCT00567697
A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO treatment 3 completed NCT01396083
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO) treatment 3 completed NCT01202461
Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME) No drug interventions treatment 1 completed NCT00612261
Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion No drug interventions treatment Not Available completed NCT05100511
Fundus Image-guided Focal Electroretinography, Usability Study No drug interventions other Not Available completed NCT00969293
Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion treatment 1 terminated NCT03739593
Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) treatment 2 completed NCT01918371
A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema Not Available Not Available completed NCT03908307
Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China treatment 4 completed NCT02688309
Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases Not Available Not Available terminated NCT01795209
Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision treatment 4 terminated NCT00668785
Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II) treatment 2 terminated NCT05130385
High Resolution Optical Coherence Tomography No drug interventions Not Available Not Available recruiting NCT02614937
Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion treatment 1 / 2 completed NCT04739137
Smart-TV Application for the Self Examination of the Distance Visual Acuity in Macular Edema Patients No drug interventions Not Available Not Available unknown_status NCT02420132
Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®) No drug interventions Not Available Not Available completed NCT00106132
Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage treatment 3 completed NCT04635800
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients No drug interventions treatment 1 completed NCT01492400
Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema treatment 2 completed NCT00411970
20- Versus 23- Gauge System for Pars Plana Vitrectomy No drug interventions treatment 4 completed NCT00055042
Laser and Antioxidant Treatment of Diabetic Macular Edema treatment 1 completed NCT04428242
Study Evaluating Retinal Health Monitoring System Thickness Module No drug interventions Not Available Not Available withdrawn NCT00994799
Comparison of Intravitreal Ranibizumab and Macular Grid-pattern Laser for Treatment of Diabetic Macular Edema Not Available Not Available unknown_status NCT04857099
Impact of the Navilas ® Micropulse Laser Treatment for Macular Edema Within the CHU Brugmann Hospital Macular Edema No drug interventions Not Available Not Available completed NCT05158699
Effectiveness of Periocular Drug Injection in CATaract Surgery prevention 3 unknown_status NCT01946399
Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF treatment Not Available terminated NCT00562406
Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES) treatment Not Available completed NCT01476449
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema treatment 2 completed NCT02485249
Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Macular Edema treatment 1 / 2 terminated NCT00486018
A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO) treatment 3 completed NCT04592419
A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) treatment 3 completed NCT03211741
Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema treatment 4 recruiting NCT01792141
Use of Diagnostic Dye to Identify Areas of Leakeage,in the Retina, Prior to Receiving Focal Laser Treatment No drug interventions Not Available Not Available completed NCT00782717
A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients prevention 2 completed NCT00797524
Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherence Tomography No drug interventions Not Available Not Available completed NCT01908816
An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. treatment 3 completed NCT01411696
Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO) Not Available Not Available completed NCT03261635
Ranibizumab Plus Indomethacin treatment 4 completed NCT00703235
Intravitreal Bevacizumab for Diabetic Macular Edema Not Available 2 / 3 unknown_status NCT06176963
A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO treatment 2 completed NCT01783886
Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement treatment 3 completed NCT01827722
Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion treatment 4 unknown_status NCT00846625
Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids treatment 2 withdrawn NCT00473330
A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE) treatment 3 completed NCT02169648
Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion treatment Not Available unknown_status NCT04140448
Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion Not Available Not Available recruiting NCT00970957
Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion treatment 3 completed NCT01396057
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO) treatment 3 completed NCT01571557
A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO) Not Available Not Available completed NCT02623426
Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial treatment 3 completed NCT03762226
Influence of Systemic Parameters in Diabetic Macular Edema - LIPSIA Study No drug interventions Not Available Not Available unknown_status NCT00791726
Microperimetry in Macular Edema No drug interventions Not Available Not Available completed NCT00280826
Efalizumab to Treat Uveitis treatment 1 completed NCT02698566
A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS) other 3 completed NCT01903720
A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion treatment 4 completed NCT04740931
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion treatment 3 completed NCT02032173
Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase treatment 3 terminated NCT00726973
Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD) treatment Not Available withdrawn NCT02623673
Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema Not Available Not Available completed NCT01273727
Ozurdex for Macular Edema Post Membrane Peeling treatment 2 / 3 completed NCT04620876
Bimodal and Coaxial High Resolution Ophtalmic Imaging No drug interventions other Not Available recruiting NCT01298076
Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema treatment 2 completed NCT02374060
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial treatment 3 completed NCT00564291
Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT) No drug interventions Not Available Not Available completed NCT01487629
Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema treatment 2 unknown_status NCT01945892
Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass Syndrome Not Available Not Available completed NCT05288192
Changes After Suprachoroidal Injection. treatment Not Available unknown_status NCT00309192
Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema treatment 3 completed NCT01030601
Analysis of the Effect of Intravitreal Dexamethasone Injection on Diabetic Macular Edema After Cataract Surgery (IDDMECS) prevention 2 completed NCT01410201
Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane treatment Not Available terminated NCT02425501
Special Drug Use Investigation of EYLEA for Diabetic Macular Edema Not Available Not Available completed NCT05038072
The Use of Suprachoroidal Triamcinolone Acetonide to Treat Macular Edema in Retinal Vein Occlusion treatment Not Available completed NCT00806169
Combined Triple Therapy in Diabetic Retinopathy (DRP) treatment 3 completed NCT01314469
Quality of Life in Patients With Intermediate Uveitis No drug interventions Not Available Not Available completed NCT01395069
Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery prevention 4 completed NCT02995746
Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane treatment Not Available terminated NCT02581995
Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME. treatment 4 completed NCT03223714
Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion treatment 3 completed NCT00407355
Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions treatment 1 / 2 completed NCT01692938
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO No drug interventions Not Available Not Available completed NCT04187443
MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema No drug interventions treatment 1 suspended NCT04499703
Evaluation of the Retinal Health Monitoring System Thickness Module No drug interventions Not Available Not Available completed NCT03603990
Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular Edema No drug interventions treatment Not Available withdrawn NCT01442064
An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2) treatment Not Available completed NCT01123564
Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion treatment 2 unknown_status NCT01660802
Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO) treatment 3 completed NCT04627402
Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE) treatment Not Available unknown_status NCT02303184
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO treatment 2 completed NCT03056079
Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept treatment 4 unknown_status NCT00027287
Laser and Medical Treatment of Diabetic Macular Edema treatment 1 completed NCT00900887
Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema treatment 2 completed NCT01231633
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO) treatment Not Available completed NCT01471054
Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma treatment 2 terminated NCT02088151
Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina No drug interventions treatment Not Available terminated NCT01427751
Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion treatment 4 completed NCT00974753
Prophylactic Ketorolac Post Epiretinal Membrane Surgery prevention Not Available completed NCT00344253
Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis treatment 3 completed NCT03203447
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO treatment 3 terminated NCT02818998
Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME) treatment 3 completed NCT00168298
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion treatment 3 completed NCT01219205
Major and Macular Branched Retinal Venous Occlusion No drug interventions treatment Not Available completed NCT03956797
Long Term Safety of Cooling Anesthesia for Intravitreal Injection No drug interventions treatment Not Available completed NCT00566761
Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO treatment 4 terminated NCT01535261
Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion treatment 3 completed NCT02403128
Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms treatment 1 unknown_status NCT03651011
Navigated Laser In Branch Retinal Vein Occlusion Study treatment Not Available completed NCT04120311
Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole treatment 1 active_not_recruiting NCT00476593
Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications basic_science Not Available completed NCT03753893
Ocular Manifestations in Rheumatic Diseases No drug interventions Not Available Not Available completed NCT05209971
Macular Thickness and Visual Acuity in Diabetic Hypertensive Patients No drug interventions Not Available Not Available unknown_status NCT04955171
BEOVU Versus Eylea in the Treatment of Diabetic Macular Edema treatment 3 unknown_status NCT03660371
ILM Peeling in PDR Patients Undergoing PPV for VH No drug interventions treatment Not Available completed NCT01428388
Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion treatment Not Available completed NCT01100307
A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema treatment 3 completed NCT02255032
Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis No drug interventions treatment 2 completed NCT03108352
Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion treatment 3 completed NCT06511700
Implementation of the Intravitreal Injection Administered by Nurses No drug interventions Not Available Not Available not_yet_recruiting NCT00906659
Visual Function, Center Point Thickness and Macular Volume After Photocoagulation No drug interventions Not Available Not Available completed NCT04601675
Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only. treatment Not Available unknown_status NCT01315275
A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema treatment 4 completed NCT01485575
Intraoperative Utility of Brilliant Blue g (Bbg) and Indocyanine Green (Icg) Assisted Chromovitrectomy No drug interventions Not Available Not Available unknown_status NCT06436170
The Role of Radial Peripapillary Vessel Density in Irvine-gass Syndrome No drug interventions Not Available Not Available completed NCT00770770
Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina treatment 2 terminated NCT00804206
Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation treatment 4 terminated NCT02217306
Contrast Sensitivity and Diabetic Macular Edema No drug interventions Not Available Not Available completed NCT00035906
Research Study in Patients With Persistent Macular Edema No drug interventions treatment 2 completed NCT00485836
A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE) treatment 3 completed NCT01023113
To Compare Visual Field Impairment in Conventional Double Frequency Nd: YAG Panretinal Photocoagulation With PASCAL Panretinal Photocoagulation No drug interventions treatment Not Available unknown_status NCT01662518
DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO) No drug interventions treatment 1 / 2 completed NCT01701518
A Pilot Study of the Effectiveness of Intra-operative Ozurdex® in Vitrectomy Surgery for Epiretinal Membranes treatment Not Available unknown_status NCT02186119
A Study of Abicipar Pegol in Patients With Diabetic Macular Edema treatment 2 completed NCT00956124
Autofluorescence in Uveitic and Diabetic Macular Edema No drug interventions Not Available Not Available withdrawn NCT00168324
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion treatment 3 completed NCT01478516
Autologous Plasmin and Fibrinolytic System in Diabetic Retinopathy No drug interventions treatment Not Available unknown_status NCT06305416
A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema treatment 3 recruiting NCT05003258
Functional and Anatomical Outcomes of Dexamethasone Intra-vitreal Implant in Patients With Resistant Macular Edema Secondary to Retinal Vein Occlusion After Intravitreal Anti-VEGF Injection No drug interventions treatment Not Available active_not_recruiting NCT02867735
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema No drug interventions treatment 1 completed NCT02850263
A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema Not Available Not Available completed NCT00668239
Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser treatment Not Available completed NCT05976139
Micropulsed Laser in Patients With Macular Oedema in Retinal Dystrophies No drug interventions treatment Not Available recruiting NCT05996822
Evaluation of Macular Edema After AcF Implant's Injection, 1 Month After the Last DXM Implant No drug interventions Not Available Not Available recruiting NCT02614625
Spectral-domain Optical Coherence Tomography of the Eye No drug interventions Not Available Not Available unknown_status NCT02956330
Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201 No drug interventions Not Available Not Available completed NCT02181530
Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX® No drug interventions Not Available Not Available completed NCT05290948
Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions treatment 2 unknown_status NCT01208948
Clinical Trial on Alpha Lipoic Acid in Diabetic Macular Edema No drug interventions prevention 3 completed NCT02399657
Effect of Dexamethasone Implant in Hard Exudate Complicated With Diabetic Macular Edema treatment 4 unknown_status NCT02887157
Analyzing Retinal Microanatomy in ROP No drug interventions Not Available Not Available completed NCT01445626
A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO) Not Available Not Available completed NCT00642226
Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO) No drug interventions treatment 3 terminated NCT00801866
Avastin for Post-photocoagulation Macular Edema treatment 4 withdrawn NCT01618266
Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion Not Available Not Available completed NCT01512966
Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema) treatment 3 completed NCT02980874
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO treatment 3 terminated NCT01247220
REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study treatment 2 completed NCT01449682
Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections. treatment 3 completed NCT00473382
A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE) treatment 3 completed NCT02188173
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME) Not Available Not Available completed NCT01579760
Intravitreal Aflibercept Injection for Radiation Retinopathy treatment 1 completed NCT01673191
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus treatment 2 completed NCT01471691
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab treatment 1 / 2 completed NCT01939691
Macular Edema Nepafenac vs. Difluprednate Uveitis Trial treatment 4 terminated NCT05372562
Risk Factors for the Recurrent Postoperative Macular Edema Treated With OZURDEX No drug interventions Not Available Not Available completed NCT02121262
A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular Edema treatment 3 completed NCT02559180
Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab treatment 4 completed NCT00886392
Diabetic Macular Edema Severity at Diagnosis No drug interventions Not Available Not Available completed NCT03056092
Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab treatment 4 unknown_status NCT00682240
Morphological and Functional Retinal Changes Following Retinal Photocoagulation No drug interventions Not Available 4 completed NCT01870440
TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema treatment 4 completed NCT03751501
Targeted Laser in Diabetic Macular Edema No drug interventions prevention Not Available unknown_status NCT03071068
A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME) No drug interventions treatment 2 completed NCT00729846
Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT) treatment 2 completed NCT01694212
Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy prevention Not Available completed NCT03161912
A Study to Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their Disease Not Available Not Available completed NCT04292912
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema treatment 1 completed NCT01771081
Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy Not Available Not Available completed NCT01331681
Intravitreal Aflibercept Injection in Vision Impairment Due to DME treatment 3 completed NCT00907114
Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy treatment 2 completed NCT00692614
A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001) treatment 2 terminated NCT04128150
High Resolution Retina Imaging No drug interventions Not Available Not Available unknown_status NCT01027650
Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO) treatment 1 / 2 completed NCT02650050
Micropulsed Laser in Association With Anti-VEGF for the Treatment of Macular Edema in Diabetic Patients (LAMED). No drug interventions treatment Not Available terminated NCT01603823
Angiographie and OCT in Macula and Retinal Diseases No drug interventions Not Available Not Available completed NCT03499223
A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME) treatment 2 completed NCT01805323
A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema Not Available Not Available completed NCT04296838
Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF treatment 2 / 3 terminated NCT03355638
Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3 treatment 4 completed